|
NIH Focus on Translational Medicine Will Hurt Drug Pipeline, Former Execs Say
JERSEY CITY, N.J. — Due to increasing pressures from Congress, the NIH is moving away from funding basic medical research and shifting toward translational work, a field once reserved for the pharmaceutical industry.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives